Approval · Notice of Compliance 15339 · 2014
ONRELTEA: Notice of Compliance 15339
Issued February 26, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15339
- Date
- February 26, 2014
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical rosacea therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONRELTEA | 02421208 | Marketed |
Medicinal ingredients
- BRIMONIDINE TARTRATE 5 MG per G